vs
Side-by-side financial comparison of Paymentus Holdings, Inc. (PAY) and Bio-Techne (TECH). Click either name above to swap in a different company.
Paymentus Holdings, Inc. is the larger business by last-quarter revenue ($330.5M vs $295.9M, roughly 1.1× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 6.3%, a 6.6% gap on every dollar of revenue. On growth, Paymentus Holdings, Inc. posted the faster year-over-year revenue change (28.1% vs -6.4%). Over the past eight quarters, Paymentus Holdings, Inc.'s revenue compounded faster (33.7% CAGR vs 4.2%).
Paymentus Holdings, Inc. is a leading cloud-based bill payment and customer engagement technology provider. It offers integrated digital payment solutions, billing automation tools, and self-service portals for enterprises across utilities, financial services, government, healthcare, and telecommunications segments, primarily operating in the North American market.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PAY vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $330.5M | $295.9M |
| Net Profit | $20.7M | $38.0M |
| Gross Margin | 25.4% | 64.6% |
| Operating Margin | 7.3% | 18.4% |
| Net Margin | 6.3% | 12.8% |
| Revenue YoY | 28.1% | -6.4% |
| Net Profit YoY | 57.2% | 68.3% |
| EPS (diluted) | $0.16 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $330.5M | $295.9M | ||
| Q3 25 | $310.7M | — | ||
| Q2 25 | $280.1M | $317.0M | ||
| Q1 25 | $275.2M | $316.2M | ||
| Q4 24 | $257.9M | $297.0M | ||
| Q3 24 | $231.6M | $289.5M | ||
| Q2 24 | $197.4M | $306.1M | ||
| Q1 24 | $184.9M | $303.4M |
| Q4 25 | $20.7M | $38.0M | ||
| Q3 25 | $17.7M | — | ||
| Q2 25 | $14.7M | $-17.7M | ||
| Q1 25 | $13.8M | $22.6M | ||
| Q4 24 | $13.1M | $34.9M | ||
| Q3 24 | $14.4M | $33.6M | ||
| Q2 24 | $9.4M | $40.6M | ||
| Q1 24 | $7.2M | $49.1M |
| Q4 25 | 25.4% | 64.6% | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 25.5% | 62.7% | ||
| Q1 25 | 24.0% | 67.9% | ||
| Q4 24 | 25.6% | 65.3% | ||
| Q3 24 | 26.2% | 63.2% | ||
| Q2 24 | 29.8% | 66.4% | ||
| Q1 24 | 28.5% | 67.4% |
| Q4 25 | 7.3% | 18.4% | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 5.7% | -7.5% | ||
| Q1 25 | 5.7% | 12.2% | ||
| Q4 24 | 5.5% | 16.0% | ||
| Q3 24 | 5.2% | 13.8% | ||
| Q2 24 | 5.2% | 15.0% | ||
| Q1 24 | 4.5% | 22.1% |
| Q4 25 | 6.3% | 12.8% | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 5.3% | -5.6% | ||
| Q1 25 | 5.0% | 7.1% | ||
| Q4 24 | 5.1% | 11.7% | ||
| Q3 24 | 6.2% | 11.6% | ||
| Q2 24 | 4.7% | 13.3% | ||
| Q1 24 | 3.9% | 16.2% |
| Q4 25 | $0.16 | $0.24 | ||
| Q3 25 | $0.14 | — | ||
| Q2 25 | $0.11 | $-0.11 | ||
| Q1 25 | $0.11 | $0.14 | ||
| Q4 24 | $0.11 | $0.22 | ||
| Q3 24 | $0.11 | $0.21 | ||
| Q2 24 | $0.07 | $0.26 | ||
| Q1 24 | $0.06 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $320.9M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $560.4M | $2.0B |
| Total Assets | $667.9M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $320.9M | $172.9M | ||
| Q3 25 | $287.9M | — | ||
| Q2 25 | $266.4M | $162.2M | ||
| Q1 25 | $245.8M | $140.7M | ||
| Q4 24 | $205.9M | $177.5M | ||
| Q3 24 | $187.5M | $187.5M | ||
| Q2 24 | $188.8M | $152.9M | ||
| Q1 24 | $180.1M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $560.4M | $2.0B | ||
| Q3 25 | $537.4M | — | ||
| Q2 25 | $516.7M | $1.9B | ||
| Q1 25 | $500.4M | $2.0B | ||
| Q4 24 | $485.6M | $2.1B | ||
| Q3 24 | $468.8M | $2.1B | ||
| Q2 24 | $451.6M | $2.1B | ||
| Q1 24 | $439.4M | $2.0B |
| Q4 25 | $667.9M | $2.5B | ||
| Q3 25 | $644.4M | — | ||
| Q2 25 | $609.5M | $2.6B | ||
| Q1 25 | $590.9M | $2.6B | ||
| Q4 24 | $576.2M | $2.7B | ||
| Q3 24 | $552.9M | $2.7B | ||
| Q2 24 | $527.7M | $2.7B | ||
| Q1 24 | $514.0M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.1M | — |
| Free Cash FlowOCF − Capex | $45.0M | — |
| FCF MarginFCF / Revenue | 13.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 2.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | $161.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | — | ||
| Q3 25 | $35.1M | — | ||
| Q2 25 | $31.5M | $98.2M | ||
| Q1 25 | $50.4M | $41.1M | ||
| Q4 24 | $27.9M | $84.3M | ||
| Q3 24 | $6.7M | $63.9M | ||
| Q2 24 | $18.0M | $75.5M | ||
| Q1 24 | $11.0M | $81.0M |
| Q4 25 | $45.0M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $31.4M | $93.3M | ||
| Q1 25 | $50.4M | $31.0M | ||
| Q4 24 | $27.8M | $77.5M | ||
| Q3 24 | $6.7M | $54.7M | ||
| Q2 24 | $17.8M | $57.5M | ||
| Q1 24 | $10.8M | $64.5M |
| Q4 25 | 13.6% | — | ||
| Q3 25 | 11.3% | — | ||
| Q2 25 | 11.2% | 29.4% | ||
| Q1 25 | 18.3% | 9.8% | ||
| Q4 24 | 10.8% | 26.1% | ||
| Q3 24 | 2.9% | 18.9% | ||
| Q2 24 | 9.0% | 18.8% | ||
| Q1 24 | 5.9% | 21.3% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.0% | 3.2% | ||
| Q2 24 | 0.1% | 5.9% | ||
| Q1 24 | 0.1% | 5.4% |
| Q4 25 | 2.18× | — | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 2.14× | — | ||
| Q1 25 | 3.65× | 1.82× | ||
| Q4 24 | 2.12× | 2.42× | ||
| Q3 24 | 0.47× | 1.90× | ||
| Q2 24 | 1.93× | 1.86× | ||
| Q1 24 | 1.52× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PAY
| Payment Transaction Processing Revenue | $326.9M | 99% |
| Other | $3.5M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
